Cases of ME/CFS Increase Following COVID-19
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Tag: long COVID
All
Latest
Cases of ME/CFS Increase Following COVID-19
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read More
Molecular ‘Fingerprint’ of Long COVID Found in Children’s Blood
Artificial intelligence identified a molecular signature of long COVID in children’s blood with 93% accuracy, according to a recent study.
Read More
Drug Candidate Improves Lung Function in Long COVID Patients
The investigational treatment improved lung function and quality of life in previously hospitalized COVID-19 patients with long-term pulmonary complications.
Read More
Repeat COVID Infections Behind Most Long COVID Cases, Four-Year Study Finds
Individuals who have had multiple COVID-19 infections appear prone to contracting long COVID, which may include symptoms such as fatigue, respiratory distress, and mental fog.
Read More
COVID-19 May Trigger Separate Chronic Condition Beyond Long COVID
New research suggests COVID-19 infection may lead to cases of a chronic condition, resembling but diagnostically separate from long COVID, characterized by persistent fatigue and post-exertional malaise.
Read More
Paxlovid May Help Some with Long-COVID After All
An up-close look at how patients respond to the drug at different times and doses adds nuance to a recent finding that Paxlovid does not work for long-COVID.
Read More
Long COVID’s Toll Extends Beyond Health Impacts
New findings suggest long COVID exacerbates financial instability for Americans, with low-income groups bearing the brunt.
Read More
Wearable TENS Device Eases Long COVID Symptoms
The transcutaneous electrical nerve stimulation device “offered immediate, on-demand relief,” say researchers.
Read More
Impaired Lung Function Linked to Brain Fog in Long COVID
A study using lung and brain MRI shows that lower pulmonary gas exchange in long COVID patients is linked to cognitive dysfunction.
Read More
Surprising Age Groups Have the Worst Long COVID Symptoms
A new study from Northwestern Medicine finds symptoms occurred regardless of mild or severe COVID-19 infection.
Read More
CDC Recommends Extra COVID-19 Shot for Seniors and High-Risk Groups
The CDC now recommends a second COVID-19 vaccine dose for people aged 65 and older, as well as those who are immunocompromised, six months after their initial dose.
Read More
Why Aren’t Some Long COVID Patients’ Lungs Healing?
A new study reveals that immune cells, typically involved in lung repair, may instead drive persistent damage and fibrosis in COVID patients, preventing proper healing.
Read More
Metformin May Protect Against Long COVID in Diabetics
NIH-backed research reveals diabetics taking metformin have a lower risk of developing long COVID or dying after infection compared to those on other diabetes medications.
Read More
Arthritis Drugs Could Treat Persistent COVID Lung Complications
New research suggests that existing FDA-approved medications may help treat lingering lung complications caused by COVID-19 by disrupting harmful immune responses.
Read More
Long COVID Symptoms Differ Between Younger Children and Adolescents
Adolescents were most likely to experience low energy/tiredness, while children were most likely to report headache.
Read More
Lab Tests Unreliable for Long COVID Diagnosis
NIH-supported research finds that routine laboratory tests are not effective in diagnosing long COVID, highlighting the need for novel biomarkers that distinguish the condition from other ailments.
Read More
Could Arthritis Drugs Alleviate Long COVID Lung Symptoms?
Researchers have identified a potential treatment for the respiratory symptoms of long COVID by discovering an unknown cause of the condition within the lungs.
Read More
Long COVID Risk Diminished After Original Strain
The risk of long COVID has decreased significantly over the course of the pandemic, and vaccination is a primary factor in reducing the risk of long COVID, according to research is published July 17 in The New England Journal of Medicine.
Read More
COVID-19 Lung Recovery Shows Surprising Regression
A study reveals long-term lung abnormalities in severe COVID-19 patients, with some showing initial recovery followed by deterioration two years later.
Read More
Virus Lurks in Long COVID Patients’ Guts for Years
UCSF research reveals that long COVID “is not a mystery,” providing evidence of virus persistence and sustained immune activation.
Read More
COVID-19 Linked to Increased Death Risk Three Years After Infection
COVID-19 patients, even those with mild cases initially, face an elevated risk of death and a range of adverse health conditions up to three years after their initial infection.
Read More
Cleveland Clinic Enrolling Long COVID patients in Clinical Trial
The Cleveland Clinic ReCOVer Clinic is enrolling Long COVID patients in the NIH RECOVER-VITAL clinical study.
Read More
NIH to Begin Long COVID Trials Addressing Sleep and Exercise Symptoms
The trials will investigate potential treatments for long COVID-related sleep disturbances, exercise intolerance, and post-exertional malaise.
Read More
DOD Awards $13M to Evaluate an Anti-inflammatory for Long COVID Treatment
The anti-inflammatory and insulin-sensitizer, which permeates the blood-brain barrier, could represent an oral treatment targeting an underlying cause of long COVID symptoms.
Read More